Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Poxel SA (7PO.MU)

Compare
0.4675
+0.0550
+(13.33%)
At close: April 17 at 8:02:20 AM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for 7PO.MU

Recent News: 7PO.MU

View More
Poxel Provides Financial Update for the First Quarter 2025 and Announces the Postponement of its 2024 Full-Year Results

Poxel Provides Financial Update for the First Quarter 2025 and Announces the Postponement of its 2024 Full-Year Results
Business Wire 2 days ago
Poxel Announces Regulatory Approval by Japanese Authorities to Expand TWYMEEG® Package Insert to Include Type 2 Diabetes Patients with Renal Impairment

Poxel Announces Regulatory Approval by Japanese Authorities to Expand TWYMEEG® Package Insert to Include Type 2 Diabetes Patients with Renal Impairment
Business Wire 10 days ago
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment

Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Business Wire 18 days ago
Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy

Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy
Business Wire 28 days ago
Poxel Reports Revenue for the Full Year 2024 and Provides an Update on its Financial Position and Outlook

Poxel Reports Revenue for the Full Year 2024 and Provides an Update on its Financial Position and Outlook
Business Wire last month
Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025
Business Wire 2 months ago
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast

Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast
Business Wire 2 months ago
Poxel Announces its Financial Calendar for 2025

Poxel Announces its Financial Calendar for 2025
Business Wire 2 months ago
Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025
Business Wire 2 months ago
Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment
Business Wire 2 months ago
Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan
Business Wire 2 months ago
View More

Related Tickers

ADOC.PA Adocia SA
3.8500
+2.67%
 
ALSEN.PA Sensorion SA
0.1700
-26.09%
 
IPH.PA Innate Pharma S.A.
1.7480
-0.46%
 
OSE.PA OSE Immunotherapeutics SA
5.90
-1.01%
 
SIGHT.PA GenSight Biologics S.A.
0.2265
-1.95%
 
ALCLS.PA Cellectis S.A.
1.3500
+0.15%
 
NANO.PA Nanobiotix S.A.
3.0000
-0.17%
 
DBV.PA DBV Technologies S.A.
1.3280
+3.59%
 
QTTB Q32 Bio Inc.
2.1200
+14.59%
 
ORIC ORIC Pharmaceuticals, Inc.
4.7700
+1.71%